Propanc Biopharma, Inc. Increase (Decrease) in Prepaid Expense
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-07-17
- Propanc Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $40.08K.
- Propanc Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$333.74K.
- Propanc Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $362.33K.
- Propanc Biopharma, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-06-30 was -$67.00.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $40.08K derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | -$293.66K derived: sum of 2 quarters · filed 2026-07-17 | $68.67K S-1 · filed 2026-07-17 | $68.60K derived: sum of 4 quarters · filed 2026-07-17 |
| 2025-12-31 | -$333.74K derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10 | $28.59K S-1 · filed 2026-04-10 | $28.52K derived: sum of 3 quarters · filed 2026-07-17 | $27.13K derived: sum of 4 quarters · filed 2026-07-17 |
| 2025-09-30 | $362.33K 10-Q · filed 2025-11-14 | $362.26K derived: sum of 2 quarters · filed 2026-07-17 | $360.87K derived: sum of 3 quarters · filed 2026-07-17 | |
| 2025-06-30 | -$67.00 derived: S-1 12 month − S-1 9 month · filed 2026-07-17 | -$1.46K derived: sum of 2 quarters · filed 2026-07-17 | -$1.38K S-1 · filed 2026-07-17 | |
| 2025-03-31 | -$1.39K derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | -$1.31K S-1 · filed 2026-07-17 | ||
| 2024-12-31 | $80.00 S-1 · filed 2026-04-10 | |||
| 2024-06-30 | -$126.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-07-17 | -$4.75K S-1 · filed 2026-07-17 | ||
| 2024-03-31 | -$4.62K 10-Q · filed 2025-05-15 |